CLINICAL_TRIALS
trial_result
· 2019-05-31
Clinical Trial Update: Study of Botulinum Toxin and Recovery of Hand Function After Stroke [Phase 3]
Summary
A Phase 3 clinical trial assessing botulinum toxin for recovery of hand function after stroke in patients with hemiparesis has completed and results were posted…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Stroke With Hemiparesis | Phase 3 | Status: COMPLETED | Results posted: 2019-05-31